Silencing H2AZ2 also significantly decreased GSC tumor initiating cell frequency as revealed by the extreme limiting dilution assay, which tracked with reduced FABP7 (a GSC marker) levels (Fig. 2C, D). The gene discussed is H2AZ2; the disease is neoplasm.